Patient-reported outcomes in patients with paroxysmal nocturnal hemoglobinuria treated with crovalimab and approved C5 inhibitors in the phase III COMMODORE 2 and 1 studies

Panse, Jens Peter; Gonzalez Fernandez, Fernando Ataulfo; Röth, Alexander; Schrezenmeier, Hubert; Gotoh, Akihiko; Kulasekararaj, Austin G.; Cermak, Jaroslav; Stefani, Jennifer; Gentile, Brittany; Sahin, Fahri; Uguen, Marianne; Ueda, Yasutaka; Han, Bing; Straetmans, Nicole; Scheinberg, Phillip; Kyselova, Olena; Chang, Alice C.

doi:0006-5242

%0 Journal Article
%A Panse, Jens Peter
%A Han, Bing
%A Cermak, Jaroslav
%A Gonzalez Fernandez, Fernando Ataulfo
%A Gotoh, Akihiko
%A Kulasekararaj, Austin G.
%A Kyselova, Olena
%A Sahin, Fahri
%A Scheinberg, Phillip
%A Schrezenmeier, Hubert
%A Straetmans, Nicole
%A Ueda, Yasutaka
%A Chang, Alice C.
%A Gentile, Brittany
%A Stefani, Jennifer
%A Uguen, Marianne
%A Röth, Alexander
%T Patient-reported outcomes in patients with paroxysmal nocturnal hemoglobinuria treated with crovalimab and approved C5 inhibitors in the phase III COMMODORE 2 and 1 studies
%J Annals of hematology
%V 104
%N 6
%@ 1432-0584
%C Berlin ; Heidelberg ; New York
%I Springer
%M RWTH-2025-10306
%P 3199-3212
%D 2025
%F PUB:(DE-HGF)16
%9 Journal Article
%U <Go to ISI:>//WOS:001508318300001
%R 10.1007/s00277-025-06449-0
%U https://publications.rwth-aachen.de/record/1022845

h1

h2

h3

h4

h5

h6

RWTH

Kontakt

RWTH Publications

Allgemeines